111 Cash Flow from Investing Activities 2018-2023 | YI
111 cash flow from investing activities from 2018 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| 111 Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $21 |
| 2022 | $-7 |
| 2021 | $9 |
| 2020 | $-50 |
| 2019 | $34 |
| 2018 | $6 |
| 2017 | $-5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.111B | $2.105B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.316B | 20.49 |
| Inspire Medical Systems (INSP) | United States | $4.614B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.995B | 0.00 |
| Axonics (AXNX) | United States | $3.446B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.976B | 0.00 |
| 10x Genomics (TXG) | United States | $2.959B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.881B | 0.00 |
| Enovis (ENOV) | United States | $2.806B | 20.79 |
| Azenta (AZTA) | United States | $2.776B | 156.00 |
| Privia Health (PRVA) | United States | $1.920B | 107.27 |
| Schrodinger (SDGR) | United States | $1.643B | 0.00 |
| Omnicell (OMCL) | United States | $1.411B | 48.78 |
| Phreesia (PHR) | United States | $1.359B | 0.00 |
| Standard BioTools (LAB) | United States | $0.749B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.669B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Talkspace (TALK) | United States | $0.475B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.445B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.408B | 0.00 |
| Pulmonx (LUNG) | United States | $0.346B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.297B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.219B | 0.00 |
| Outset Medical (OM) | United States | $0.187B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.173B | 0.00 |
| American Well (AMWL) | United States | $0.151B | 0.00 |
| TruBridge (TBRG) | United States | $0.135B | 7.26 |
| MSP Recovery (LIFW) | United States | $0.099B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.080B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.056B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Cue Health (HLTH) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |